Effects of clinicopathological factors on prognosis of young patients with resected breast cancer
- PMID: 33592828
- PMCID: PMC7870259
- DOI: 10.1097/MD.0000000000023693
Effects of clinicopathological factors on prognosis of young patients with resected breast cancer
Abstract
This study aims to analyze the relationship between clinicopathological characteristics and survival in young patients (≤35 years old) with resected breast cancer.A total of 173 cases were included in this study. The clinicopathological factors potentially associated with prognosis were evaluated. Furthermore, we categorized patients into different groups to evaluate the prognosis according to hormone receptor status or important risk factors.Younger age (≤30 years) was an independent predictor for poor disease-free survival (DFS) and overall survival (OS). Besides, PR negative status, tumor grade, and advanced lymph nodes postsurgery were independent prognostic factors of DFS, while PR negative status and advanced lymph nodes postsurgery were independent prognostic factors of OS. For hormone receptor-positive patients, people with ER+ or PR+ and HER2-/+ showed poorer prognosis than the other 2 levels. Risk factor grouping based on the ER, PR, HER2, Ki-67 status, tumor grade, and lymph nodes postsurgery showed that patients in highest score group received the poorest prognosis. Grading system based on the hormone status or the risk factor grouping may offer a useful approach to assess which subgroups of young breast cancer present poorer prognosis.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interests to disclose.
Figures



Similar articles
-
Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer.Clin Transl Oncol. 2020 Dec;22(12):2275-2285. doi: 10.1007/s12094-020-02369-9. Epub 2020 May 23. Clin Transl Oncol. 2020. PMID: 32447641
-
Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13. Breast J. 2013. PMID: 23240985
-
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.World J Surg Oncol. 2016 Sep 13;14(1):244. doi: 10.1186/s12957-016-0999-x. World J Surg Oncol. 2016. PMID: 27619909 Free PMC article.
-
Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.Asian Pac J Cancer Prev. 2015;16(2):823-9. doi: 10.7314/apjcp.2015.16.2.823. Asian Pac J Cancer Prev. 2015. PMID: 25684532
-
Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.Hum Pathol. 2017 Oct;68:166-174. doi: 10.1016/j.humpath.2017.08.032. Epub 2017 Sep 9. Hum Pathol. 2017. PMID: 28899737 Review.
Cited by
-
Occupational Exposure to Pesticides Affects Pivotal Immunologic Anti-Tumor Responses in Breast Cancer Women from the Intermediate Risk of Recurrence and Death.Cancers (Basel). 2022 Oct 23;14(21):5199. doi: 10.3390/cancers14215199. Cancers (Basel). 2022. PMID: 36358618 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous